AMPs are cationic peptides, typically 12–50 peptides in length, and demonstrate antimicrobial properties against treatment-resistant pathogens. A University of Pittsburgh researcher has developed novel cationic antimicrobial peptides (AMPs) through modification of secondary structure and the associated amphipathic characteristics. Based on peptides in existing AMPs the secondary structure has been scrambled to change the amphipathic from helical to linear.
4D printing, in which printed objects demonstrate functional responses to stimuli, represents the very forefront of additive manufacturing technology. The monomer can be changed between subsequent layers, introducing functional gradations that can elicit dynamic and varied response profiles in the finished structure.
Peptide studies to date are incremental and tailored to a single best peptide. Deciphering the therapeutic code of cationic peptides for the treatment of cancer and infections associated with antibiotic resistant bacteria. Although current treatments include natural antimicrobial peptides (AMPs), they pose several challenges for clinical applications, notably lack of in vivo efficacy and potential toxicity to mammalian cells.